Healthcare -
Biotechnology - NYSE - CH
$ 1.635
-7.1 %
$ 158 M
Market Cap
-0.68
P/E
ADCT - NET INCOME
Net Income ADCT - ADC Therapeutics SA
-240 M
LAST VALUE
-2.16%
2 YEAR CAGR
-14.29%
5 YEAR CAGR
0.00%
10 YEAR CAGR